• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The U.S. Market For Cardiovascular Devices

$3,500.00 – $7,000.00

Clear
SKU: KLI1099234 Category: Medical Devices Market Research Pages: 402
  • Description
  • Table of Contents
  • Latest reports

Description

This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments:

  • cardiomyopathy/congestive heart failure
  • arrhythmias
  • arteriosclerosis (coronary artery disease), and
  • valvular heart disease

While there are other cardiovascular conditions that remain significant in the American population, e.g., stroke and myocardial infarction, these four conditions present the core conditions that lead to more serious cardiovascular accidents and death and present the opportunity for the therapeutic device market.

This report discusses the market for specific therapeutic device products for the cardiovascular market in terms of their potential in the population in the United States as a whole and in the 45-years-old and older subsegment of the U.S. population through 2014. Market potential is used as opposed to a rehash of experienced and projected revenues for several reason for this:

  • A large number of therapeutic applications for cardiovascular disease are currently in development and are based on advanced technology in therapeutic device design and development.
  • Because much of the potential use of new therapeutics is not associated with commonly available databases, it is often impossible to determine their level and type of their application in the growing market environments.
  • The status of the current market in terms of revenues is misleading of the potential market as a whole. It does not allow for the understanding of the potential of unmet need, which will be discussed in the various sections of this report, and is in no way reflected by the current revenue picture for therapeutic cardiovascular devices.

As a result, we believe these market assessments provide a more realistic view of the opportunities available to those who are engaged or interested in addressing them. The key is in understanding how much of this potential has actually been realized and how much is unmet need.

The analysis presented in this report is based on data from a combination of company, government, industrial, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including experts in cardiology, cardiac surgery, vascular surgery, internal medicine, and gerontology, as well as research scientists, and business development and marketing managers within the medical devices, industries. The analyses are based on:

  • The current and expected levels of research and development for age-related cardiovascular disease therapeutic devices
  • The general trends in population demographics; epidemiology of cardiomyopathy/congestive heart failure, arrhythmia, arteriosclerosis, and valvular heart disease; and other factors that affect those trends
  • The trends in approaches to cardiovascular disease prevention
  • Costs analysis based on studies of actual research and projected costs of new cardiovascular disease therapeutic products by those engaged in their development.

 

Table of Contents

CHAPTER ONE: Executive Summary

  • Background
  • Cardiomyopathy/Congestive Heart Failure
    • Left Ventricular (LV) Failure
    • Right Ventricular (RV) Failure
    • Systolic Dysfunction
    • Diastolic Dysfunction
    • High Output Failure
  • Arrhythmias
  • Arteriosclerosis (Coronary Artery Disease)
  • Heart Valve Disease
  • Scope and Methodology
  • Size and Growth of Market
  • Competitive Picture
  • Market Trends and Factors

CHAPTER tWO: Overview of Cardiovascular Disease

  • Background
  • Aneurysm
  • Arrhythmias
  • Athletic Heart Syndrome
  • Cardiac Arrest
  • Cardiac Tumors
  • Cardiomyopathy
  • Congenital Heart Disease
  • Congestive Heart Failure
    • Types of Heart Failure
    • Left Ventricular (LV) Failure
    • Right Ventricular (RV) Failure
    • Systolic Dysfunction
    • Diastolic Dysfunction
    • High Output Failure
    • Theories of Heart Failure
    • Hemodynamic Response Theory
    • Neurohormonal Response Theory
    • Renal Response Theory
  • Coronary Artery Disease
  • Endocarditis
    • Infective Endocarditis
    • Subacute bacterial endocarditis (SBE)
    • Acute bacterial endocarditis (ABE)
    • Prosthetic valvular endocarditis
    • Right-sided endocarditis
    • Noninfective Endocarditis
  • Hypertension/Hypotension
  • Pericardial Disease
  • Shock
    • Hypovolemic shock
    • Vasodilatory shock
    • Cardiogenic shock
  • Valvular Heart Disease
  • Vascular Disease

CHAPTER THREE: Demographics and Epidemiology

  • Background
  • Population Demographics
  • Epidemiology and Pathology of Cardiovascular Diseases
  • Cardiomyopathy/Congestive Heart Failure (CHF)
    • Types of Heart Failure
    • Left Ventricular (LV) Failure
    • Right Ventricular (RV) Failure
    • Systolic Dysfunction
    • Diastolic Dysfunction
    • High Output Failure
    • Theories of Congestive Heart Failure
    • Hemodynamic Response Theory
    • Neurohormonal Response Theory
    • Renal Response Theory
    • Conditions Leading to Congestive Heart Failure
  • Arrhythmias
  • Arteriosclerosis/Atherosclerosis
  • Heart Valve Disease

CHAPTER FOUR: Therapeutic Cardiovascular Devices

  • Overview
  • Prosthetic Heart Valves
  • Pacemakers
  • Implantable Cardioverter-Defibrillators (ICDs)
  • Ventricular Assist Devices (VADs)
  • Total Artificial Heart Devices (TAHs)
  • Coronary Artery Stents
  • Cardiac Support Devices

CHAPTER FIVE: Market Analysis

  • Market Size and Growth Overview
    • Cardiomyopathy/Congestive Heart Failure (CHF)
    • Arrhythmia
    • Arteriosclerosis
    • Heart Valve Diseases
  • The 45+-Year-Old Market: A General View
    • Cardiomyopathy/Congestive Heart Failure
    • Arrhythmias
    • Arteriosclerosis
    • Valvular Heart Disease
  • Competitive Outlook
  • Market Trends

CHAPTER SIX: Company Profiles

  • Overview
  • Abbott Vascular Devices Division of Abbott Laboratories
  • Abiomed, Inc.
  • Acorn Cardiovascular, Inc.
  • Arrow International
  • Boston Scientific Corp.
  • Cordis Corporation (A Johnson & Johnson Company)
  • Guidant Corporation A Johnson & Johnson Company
  • Medtronic, Inc.
    • Cardiac Rhythm Management (CRM)
    • Vascular
    • Cardiac Surgery
  • MicroMed Technology, Inc.
  • Myocor, Inc.
  • St. Jude Medical
  • Somanetics Corporation
  • Somanetics Corporation
  • Thoratec Corporation

Chapter Seven: Conclusions and Strategic Implications

  • First Conclusion
  • Implications:
  • Second Conclusion
  • Implications:
  • Third Conclusion
  • Implications:
  • Fourth Conclusion
  • Implications:
  • Fifth Conclusion
  • Implications:
  • Sixth Conclusion
  • Implications:
  • Seventh Conclusion
  • Implications:
  • Eighth Conclusion
  • Implications:
  • Ninth Conclusion
  • Implications:
  • Tenth Conclusion
  • Implications:
  • Eleventh Conclusion
  • Implications:
  • Twelfth Conclusion
  • Implications:
  • Thirteenth Conclusion
  • Implications:

APPENDIX A: Company Directory

APPENDIX B: Glossary

List of Exhibits

CHAPTER ONE: Executive Summary

  • Table 1-1: Prevalence of Selected Cardiovascular Diseases in the United States for the Total Population and Those 45 Years of Age and Older 2004-2014
  • Figure 1-1: Trending in United States Cardiovascular Disease Prevalence in the General Population and the 45+ Year Old Age Group 2004 – 2014
  • Figure 1-2: Trending in U.S. Cases of Cardiomyopathy/Congestive Heart Failure 2004-2014
  • Figure 1-3: Trending in U.S. Cases of Arrhythmia 2004-2014
  • Figure 1-4: Trending in United States Cases of Arteriosclerosis (Coronary Artery Disease): 2004-2014
  • Figure 1-5: Trending in U.S. Cases of Valvular Heart Disease 2004-2014
  • Table 1-2: The Projected U.S. Total Available Market Potential of Therapeutic Devices for Cardiovascular Diseases by Type (Congestive Heart Failure, Arrhythmia, Arteriosclerosis and Heart Valve Disease) in the General Population and the Population Aged 45 Years and Older 2004-2014
  • Figure 1-6: The Projected U.S. Total Available Market Potential of Therapeutic Devices for Cardiovascular Diseases in the General Population and the Population Aged 45 Years and Older 2004-2014
  • Table 1-3: Key Competitors in the Therapeutic Cardiovascular Device Markets

CHAPTER tWO: Overview of Cardiovascular Disease

  • Table 2-1: Benign and Malignant Cardiac Tumors
  • Table 2-2: Common Contributors to Congestive Heart Failure

CHAPTER THREE: Demographics and Epidemiology

  • Figure 3-1: Growth of the World’s Elderly (60+ Years) Population 2001 – 2025
  • Figure 3-2: Population Distribution of the United States by Age and Sex for 2000, 2005 and 2010
  • Figure 3-3: The Growing United States Population: 2004-2014
  • Figure 3-4: Projected Increasing Median Age of the United States Population: 2004-2014
  • Figure 3-5: Projected Increasing Mean Age of the United States Population: 2004-2014
  • Table 3-1: Prevalence of Selected Cardiovascular Diseases (CVD) in the United States for the Total Population and Those 45 Years of Age and Older: 2004 – 2014
  • Figure 3-6: Trending in United States Selected Cardiovascular Disease (CVD) Cases in the General Population and the 45+ Year Old Age Group: 2004 – 2014
  • Table 3-2: Prevalence Statistics for Different Types of Cardiomyopathy in the United States
  • Table 3-3: Common Contributors to Congestive Heart Failure
  • Table 3-7: Trending in the Prevalence of Cardiomyopathy/Congestive Heart Failure in the United States (Total Population and Those Aged 45 Year and Older) 2004-2014
  • Table 3-4: Types of Arrhythmias
  • Table 3-5: Prevalence Statistics for Types of Arrhythmias in the United States (22 types)
  • Table 3-8: Trending in the Prevalence of Arrhythmia in the United States (Total Population and Those Aged 45 Year and Older) 2004-2014
  • Table 3-9: Trending in the Prevalence of Arteriosclerosis (CAD) in the United States (Total Population and Those Aged 45 Year and Older) 2004-2014
  • Table 3-10: Trending in the Prevalence of Heart Valve Disease in the United States (Total Population and Those Aged 45 Year and Older) 2004-2014

CHAPTER FOUR: Therapeutic Cardiovascular Devices

  • Table 4-1: Key Providers of Prosthetic Heart Valves
  • Table 4-2: Key Providers of Pacemakers
  • Table 4-3: Key Providers of ICDs
  • Table 4-4: Key Providers of VADs
  • Table 4-5: Key Providers of TAHs
  • Table 4-6: Candidate Drugs for Drug-Eluting Stents
  • Table 4-7: Companies Active in Drug-Eluting Stent Commercialization
  • Table 4-8: Key Providers of Cardiac Support Devices

CHAPTER FIVE: Market Analysis

  • Table 4-1: The Projected U.S. Total Available Market Potential for Therapeutic Devices by Condition (Arteriosclerosis, Cardiomyopathy/Congestive Heart Failure, Arrhythmia and Heart Valve Disease) 2004-2014
  • Figure 4-1: Trending in the Projected U.S. Total Available Market Potential Therapeutic Devices by Condition (Arteriosclerosis, Cardiomyopathy/Congestive Heart Failure, Arrhythmia and Heart Valve Disease) 2004-2014
  • Figure 4-2: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices Used for the Treatment of Cardiomyopathy/Congestive Heart Failure 2004-2014
  • Figure 4-3: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Arrhythmias 2004-2014
  • Figure 4-4: Trending in the Projected U.S. Total Available Market Potential for the Therapeutic Cardiovascular Devices in the Treatment of Arteriosclerosis 2004-2014
  • Figure 4-5: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Heart Valve Diseases 2004-2014
  • Table 4-2: The Projected U.S. Total Available Market Potential for Therapeutic Devices in the 45+ Year Old Age Group by Condition (Arteriosclerosis, Cardiomyopathy/Congestive Heart Failure, Arrhythmia, and Heart Valve Disease) 2004-2014
  • Figure 4-6: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Devices in the 45+ Year Old Age Group by Condition (Arteriosclerosis, Cardiomyopathy/Congestive Heart Failure, Arrhythmia, and Heart Valve Disease) 2004-2014
  • Figure 4-7: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Cardiomyopathy/Congestive Heart Failure in the 45+-Year-Old Population 2004-2014
  • Figure 4-8: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Arrhythmias in the 45+-Year-Old Population 2004-2014
  • Figure 4-9: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Arteriosclerosis in the 45+-Year-Old Population 2004-2014
  • Figure 4-10: Trending in the Projected U.S. Total Available Market Potential for Therapeutic Cardiovascular Devices in the Treatment of Heart Valve Disease in the 45+-Year-Old Population 2004-2014

 

    Global Market for Medical Devices, 14th Edition
    October 31, 2024
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    The Global Market for Medical Devices, 13th Edition
    October 25, 2023
    The Market for Medical Devices, 12th Edition
    November 9, 2022

Related products

  • Placeholder image

    Wound Care Markets Volume II: Burns

    $1,875.00 – $3,750.00
  • Placeholder image

    Wound Care Markets, 2nd Edition, Vol III – Surgical and Trauma Wounds

    $2,995.00 – $5,990.00
  • Placeholder image

    Diabetes in Japan: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

    $371.00 – $742.00
  • Placeholder image

    Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Wound Care Markets, 2nd Edition, Vol II – BurnsU.S. Market for Clinical Information Systems – An Analysis of the Growing...
Scroll to top